HELE Stock Analysis: Helen of Troy | NASDAQ
Household & Personal Products | NASDAQ, USA | Market Cap: 668m USD | 12M Return: 29.6% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 16.9M
EPS Trend: -90.1%
Qual. Beats: 0
Rev. Trend: -97.1%
Qual. Beats: 2
Warnings
Tailwinds
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Helen of Troy Limited (NASDAQ: HELE) is a Texas-based, multi-brand consumer products company that designs, markets, and distributes a diverse portfolio of household and personal care goods through two reporting segments: Home & Outdoor and Beauty & Wellness. The Home & Outdoor segment covers food storage, kitchen tools, insulated beverageware, and outdoor packs and bags, while the Beauty & Wellness segment spans grooming tools, hair appliances, nail care, and health and home environment products such as thermometers, air purifiers, and water filtration systems.
The company operates a brand-licensing and owned-brand hybrid model, marketing its products under names including OXO, Hydro Flask, Osprey, Hot Tools, Drybar, Curlsmith, and Olive & June, alongside licensed brands such as Braun, Honeywell, PUR, Vicks, and Revlon. It reaches consumers through a broad omnichannel distribution network that includes mass merchandisers, specialty retailers, e-commerce platforms, warehouse clubs, and direct-to-consumer channels across North America, Europe, the Middle East, Africa, Asia Pacific, and Latin America.
Classified within the Consumer Discretionary sector under the Household Appliances sub-industry, HELE follows a roll-up acquisition strategy commonly seen in the consumer products space, using brand acquisitions to enter and expand across product categories. Founded in 1968 and headquartered in El Paso, Texas, the company has been publicly traded since its 1990 IPO and is currently positioned as a small-cap equity.
- China sourcing exposure heightens tariff cost pressure
- Beauty segment acquisitions face integration and margin challenges
- Hydro Flask and Osprey outdoor brands drive Home & Outdoor growth
| Net Income: -412.5m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.04 > 0.02 and ΔFCF/TA -0.35 > 1.0 |
| NWC/Revenue: 20.70% < 20% (prev 18.84%; Δ 1.86% < -1%) |
| CFO/TA 0.05 > 3% & CFO 112.2m > Net Income -412.5m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 1.78 > 1.5 & < 3 |
| Outstanding Shares: last quarter (23.8m) vs 12m ago 3.55% < -2% |
| Gross Margin: 45.44% > 18% (prev 47.59%; Δ -2.15% > 0.5%) |
| Asset Turnover: 76.79% > 50% (prev 70.23%; Δ 6.56% > 0%) |
| Interest Coverage Ratio: -5.68 > 6 (EBIT TTM -313.8m / Interest Expense TTM 55.2m) |
| A: 0.18 (Total Current Assets 856.3m - Total Current Liabilities 480.2m) / Total Assets 2.08b |
| B: 0.22 (Retained Earnings 448.5m / Total Assets 2.08b) |
| C: -0.13 (EBIT TTM -313.8m / Avg Total Assets 2.37b) |
| D: 0.68 (Book Value of Equity 843.5m / Total Liabilities 1.24b) |
| Altman-Z'' = 1.71 = BBB |
| DSRI: 1.05 (Receivables 332.8m/323.5m, Revenue 1.82b/1.86b) |
| GMI: 1.05 (GM 47.59% / 45.44%) |
| AQI: 0.82 (AQ_t 0.44 / AQ_t-1 0.54) |
| SGI: 0.98 (Revenue 1.82b / 1.86b) |
| TATA: -0.25 (NI -412.5m - CFO 112.2m) / TA 2.08b) |
| Beneish M = -3.09 (Cap -4..+1) = AA |
As of July 20, 2026, the stock is trading at USD 28.10 with a total of 365,470 shares traded. Over the past week, the price has changed by +6.68%, over one month by +8.08%, over three months by +42.06% and over the past year by +29.55%.
Current recommended Stop Loss: 23.50 (which is 16.4% or 2.6 ATR below the current price).
Helen of Troy has received a consensus analysts rating of 3.25. Therefore, it is recommended to hold HELE.
- StrongBuy: 0
- Buy: 1
- Hold: 3
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 31 | 10.3% |
P/E Forward = 8.0386
P/S = 0.3676
P/B = 0.7748
P/EG = 0.9718
Revenue TTM = 1.82b USD
EBIT TTM = -313.8m USD
EBITDA TTM = -261.2m USD
Long Term Debt = 691.1m USD (from longTermDebt, last quarter)
Short Term Debt = 25.0m USD (from shortTermDebt, last quarter)
Debt = 826.5m USD (from shortLongTermDebtTotal, last quarter) + Leases 55.2m
Net Debt = 802.4m USD (calculated: Debt 826.5m - CCE 24.2m)
Enterprise Value = 1.47b USD (667.8m + Debt 826.5m - CCE 24.2m)
Interest Coverage Ratio = -5.68 (Ebit TTM -313.8m / Interest Expense TTM 55.2m)
EV/FCF = 18.26x (Enterprise Value 1.47b / FCF TTM 80.5m)
FCF Yield = 5.48% (FCF TTM 80.5m / Enterprise Value 1.47b)
FCF Margin = 4.43% (FCF TTM 80.5m / Revenue TTM 1.82b)
Net Margin = -22.71% (Net Income TTM -412.5m / Revenue TTM 1.82b)
Gross Margin = 45.44% ((Revenue TTM 1.82b - Cost of Revenue TTM 991.2m) / Revenue TTM)
Gross Margin QoQ = 45.97% (prev 44.61%)
Tobins Q-Ratio = 0.71 (Enterprise Value 1.47b / Total Assets 2.08b)
Interest Expense / Debt = 6.68% (Interest Expense 55.2m / Debt 826.5m)
Taxrate = 26.00% (12.6m / 48.3m)
NOPAT = -232.2m (EBIT -313.8m * (1 - 26.00%)) [loss with tax shield]
Current Ratio = 1.78 (Total Current Assets 856.3m / Total Current Liabilities 480.2m)
Debt / Equity = 0.98 (Debt 826.5m / totalStockholderEquity, last quarter 843.5m)
Debt / EBITDA = -3.07 (negative EBITDA) (Net Debt 802.4m / EBITDA -261.2m)
Debt / FCF = 9.97 (Net Debt 802.4m / FCF TTM 80.5m)
Total Stockholder Equity = 855.1m (last 4 quarters mean from totalStockholderEquity)
RoA = -17.43% (Net Income -412.5m / Total Assets 2.08b)
RoE = -48.24% (Net Income TTM -412.5m / Total Stockholder Equity 855.1m)
RoCE = -20.29% (EBIT -313.8m / Capital Employed (Equity 855.1m + L.T.Debt 691.1m))
RoIC = -14.51% (negative operating profit) (NOPAT -232.2m / Invested Capital 1.60b)
WACC = 8.07% (E(667.8m)/V(1.49b) * Re(11.94%) + D(826.5m)/V(1.49b) * Rd(6.68%) * (1-Tc(0.26)))
Discount Rate = 11.94% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -19.72 | Cagr: -0.25%
[DCF] Terminal Value 73.10% ; FCFF base≈93.1m ; Y1≈81.6m ; Y5≈65.9m
[DCF] Fair Price = 11.00 (EV 1.06b - Net Debt 802.4m = Equity 256.1m / Shares 23.3m; r=8.35% [WACC [floored]]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: -90.05 | EPS CAGR: -29.35% | SUE: 0.18 | # QB: 0
Revenue Correlation: -97.15 | Revenue CAGR: -4.54% | SUE: 1.47 | # QB: 2
EPS current Quarter (2026-08-31): EPS=0.50 | Chg30d=+2.75% | Revisions=+50% | Analysts=4
EPS next Quarter (2026-11-30): EPS=1.65 | Chg30d=-10.42% | Revisions=-17% | Analysts=4
EPS current Year (2027-02-28): EPS=3.59 | Chg30d=+2.10% | Revisions=+17% | GrowthEPS=+1.2% | GrowthRev=+1.4%
EPS next Year (2028-02-29): EPS=4.00 | Chg30d=-1.52% | Revisions=+0% | GrowthEPS=+11.4% | GrowthRev=+1.9%
[Analyst] Revisions Ratio: +21% (up=7, down=4)